MDGL Stock-Based Compensation
Madrigal Pharmaceuticals Inc · Stock-Based Compensation
MDGL Stock-Based Compensation
Latest reported$35.37Mperiod ending
MDGL Quarterly Stock-Based Comp ($0.00 → $35.37M)
Quarterly stock-based compensation
High-resolution chart · PNG
MDGL stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 35,371,000 | |
| 34,018,000 | |
| 0 | |
| 26,252,000 | |
| 25,159,000 | |
| 20,931,000 | |
| 17,676,000 | |
| 17,898,000 | |
| 24,404,000 | |
| 19,902,000 | |
| 14,852,000 | |
| 12,660,000 | |
| 10,973,000 | |
| 11,250,000 | |
| 8,082,000 | |
| 8,122,000 | |
| 7,944,000 | |
| 7,477,000 | |
| 6,356,000 | |
| 6,242,000 | |
| 8,179,000 | |
| 6,096,000 | |
| 5,134,000 | |
| 5,061,000 | |
| 5,689,000 | |
| 4,846,000 | |
| 4,032,000 | |
| 4,950,000 | |
| 7,755,000 | |
| 6,022,000 | |
| 5,119,000 | |
| 4,976,000 | |
| 2,227,000 | |
| 1,167,000 | |
| 947,000 | |
| 1,029,000 | |
| 676,000 | |
| 602,000 | |
| 576,235 | |
| 7,109,939 | |
| 545,000 | |
| 448,000 | |
| 579,000 | |
| 1,168,000 | |
| 843,000 | |
| 1,710,000 | |
| 1,766,000 | |
| 1,566,000 | |
| 1,513,000 | |
| 2,586,000 | |
| 1,540,000 | |
| 1,683,000 | |
| 1,591,000 | |
| 1,216,000 | |
| 963,000 | |
| 801,000 | |
| 731,000 | |
| 827,000 | |
| 848,000 | |
| 867,000 | |
| 812,000 | |
| 827,000 | |
| 863,000 | |
| 963,000 | |
| 1,135,000 | |
| 1,087,000 | |
| 1,115,000 | |
| 1,252,000 | |
| 1,047,000 | |
| 1,165,000 | |
| 7,572,000 | |
| 0 | |
| 0 | |
| 2,136,000 | |
| 5,417,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |